Whose World Cup is it?: As visas tighten, prices soar and teams fall away, the ‘global’ game feels increasingly exclusiveThe upcoming FIFA World Cup faces major hurdles. Many popular teams will not participate. Ticket prices have surged dramatically, making at...
Italy hoping to scale World Cup 'Everest' ahead of Bosnia play-off showdownItaly have one more obstacle standing between them and a return to the World Cup in the shape of Bosnia and Hercegovina, who host the Azzur...
Time has never been better for Pharma breakthroughs than today: Bayer executive Stefan OelrichBayer, the renowned pharmaceutical powerhouse from Germany, is implementing a tiered pricing strategy on a global scale to make medications...
India cannot become developed nation with 'backward agriculture': Bayer South Asia PrezIndia's agriculture sector must modernize to achieve developed nation status by 2047, says Bayer South Asia head Simon Wiebusch. He commend...
Joe Biden has trouble putting two sentences together, says Virginia DemocratA member of the US House of Representatives from the state of Virginia has said the US President is finding it tough to put two sentences t...
Bayer Leverkusen's potential Bundesliga triumph brings shifts in fan sentimentsBayer Leverkusen, led by Xabi Alonso, seeks to end Bayern Munich's reign by winning its first national title. The club faces challenges in ...
Matthias Berninger on COP28: Prioritizing impact over pledgesThe former German politician and member of the Greens says that “a kind of COP related nervousness and energy” around commitments is “somet...
In a race with HCQ, remdesivir and Coronil, Paracetamol has witnessed a sudden rise in demandSudden demand for paracetamol has been taken to be a possible clue to people concealing Covid-19 at home. People who have, or think they ha...
Bayer's chloroquine donation to U.S. raises concern about FDA standards in pandemicOn Mar 21, two days after President Trump first touted chloroquine drugs as a "gamechanger" in the fight against COVID-19, administration o...
Bayer sees delays, expects to close $66-billion Monsanto deal by early 2018Bayer had in September 2016 agreed to take over Monsanto for USD 66 billion, ending months of wrangling with a third sweetened offer that m...
How this $66 billion deal turned ‘oracle’ Warren Buffett into an arbitragerWe don't know for sure if it was Buffett himself or one of his stock-picking deputies who made the investment. Either way, he no doubt gave...
- Soccer-Leaders Leipzig happy to stir up Bundesliga "hornets nest"
SOCCER-GERMANY/LEIPZIG (TV):Soccer-Leaders Leipzig happy to stir up Bundesliga "hornets nest"
Cheap data can usher in green revolution 2.0Availability of affordable data will help farmers get important information at a time when the world is fast moving towards 'digital farmin...
Cipla shocks rivals by slashing cancer drug prices up to 75%Kidney cancer drug will now be available at Rs 6,840 for a month's supply, down from Rs 28,000. Lung cancer drug will cost Rs 4,250, down f...
Natco victory could encourage other generic companies also to apply for compulsory licenceEarlier this week, a ruling effectively cut the price of high-cost cancer drug Sorafenib by 97%. But that’s just one of many legal battles ...
Curb prices of costly imported medicines before issuing compulsory licencesIt would safeguard India's ability to export drugs made under compulsory licences issued by a third country.
- See a price target of 925-950 for Bayer Corp.: Gaurang Shah
Gaurang Shah, Asst VP, Geojit BNP Paribas Financial Services in a chat with ET Now gives his perspective on Bayer Corp.